Literature DB >> 9618219

Alternative Splicing of Human NrCAM in Neural and Nonneural Tissues.

.   

Abstract

Neural cell adhesion molecule NrCAM exists in a variety of isoforms as a result of alternative splicing of individual exons during RNA processing. In this report we demonstrate that many of the alternative splicing events described for chick are conserved in man and describe a novel variant of NrCAM cDNA. Furthermore, we show that NrCAM is expressed at significant levels outside the nervous system; in particular in pancreas, adrenal glands, and placenta and that expression in both brain and other tissues is accompanied by a very variable pattern of exon utilization in fetal and adult cells. Copyright 1998 Academic Press.

Entities:  

Year:  1998        PMID: 9618219     DOI: 10.1006/mcne.1997.0658

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  5 in total

1.  Deposition of the NG2 proteoglycan at nodes of Ranvier in the peripheral nervous system.

Authors:  S Martin; A K Levine; Z J Chen; Y Ughrin; J M Levine
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

2.  Plasma biomarkers for neuronal ceroid lipofuscinosis.

Authors:  Samantha L Hersrud; Ryan D Geraets; Krystal L Weber; Chun-Hung Chan; David A Pearce
Journal:  FEBS J       Date:  2015-12-17       Impact factor: 5.542

3.  Alternative Splicing of Nrcam Gene in Dorsal Root Ganglion Contributes to Neuropathic Pain.

Authors:  Lingli Liang; Shaogen Wu; Corinna Lin; Yun-Juan Chang; Yuan-Xiang Tao
Journal:  J Pain       Date:  2020-01-07       Impact factor: 5.820

4.  LAD-1, the Caenorhabditis elegans L1CAM homologue, participates in embryonic and gonadal morphogenesis and is a substrate for fibroblast growth factor receptor pathway-dependent phosphotyrosine-based signaling.

Authors:  L Chen; B Ong; V Bennett
Journal:  J Cell Biol       Date:  2001-08-13       Impact factor: 10.539

5.  NrCAM, a neuronal system cell-adhesion molecule, is induced in papillary thyroid carcinomas.

Authors:  B Górka; J Skubis-Zegadło; M Mikula; K Bardadin; E Paliczka; B Czarnocka
Journal:  Br J Cancer       Date:  2007-07-31       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.